Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...

Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Hims and Hers is an online platform that connects patients with licensed healthcare professionals and offers treatments for a range of conditions, including hair loss and sexual wellness ...

It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.

Hims & Hers Health Inc. has been on a meteoric rise, with shares soaring over 145% this year and more than sixfold in the ...

Well, it happened. The telehealth platform initially launched as an online platform for men to discreetly secure hair loss and erectile dysfunction drugs. Hims & Hers has been an impressive growth ...

Nutrafol’s latest product ushers the brand into new (hair care) territory. And it’s a terrific option for guys with short ...